Loading
Latest filing published 12 Dec 2025 for Remus Pharmaceuticals Limited, €3,457.
All filings by Vinodkumar Gandalal Shah on record concern Remus Pharmaceuticals Limited. In total, 6 filings cover trades dated from 30 December 2024 to 10 December 2025.
On the open market, the record shows 5 purchases worth €8,840 and 1 sale worth €1,432. Netting one side against the other leaves €7,408 of net buying. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2025: 5 purchases and 1 sale on the market.
The median purchase comes to €1,349. No cluster: in 5 purchases, no other insider of the company bought within 30 days.
The record was last updated on 12 December 2025 with an open-market purchase (€3,457) in Remus Pharmaceuticals Limited. Between a trade and the moment it shows up on SEBI (PIT + SAST), the median delay is 3 days. Until a filing is published, the market cannot know about the trade. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations